Effect of histamine on intercellular adhesion molecule-1 expression and production of interferon-γ and interleukin-12 in mixed lymphocyte reaction stimulated with interleukin-18

Transplantation

Volumn 74, Issue 6, 2002, Pages 864-870

  Itoh, Hideyuki ^a   Takahashi, Hideo K ^a   Iwagaki, Hiromi ^a   Yoshino, Tadashi ^a   Morimoto, Yoshinori ^a   Saito, Shinnya ^a   Yagi, Takahito ^a   Akagi, Tadaatsu ^a   Nishibori, Masahiro ^a   Tanaka, Noriaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 PYRIDYL)ETHYLAMINE; 4 METHYLHISTAMINE; ALPHA METHYLHISTAMINE; DEXCHLORPHENIRAMINE; DIMAPRIT; FAMOTIDINE; GAMMA INTERFERON; HISTAMINE; HISTAMINE H1 RECEPTOR AGONIST; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR AGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; RECEPTOR SUBTYPE; RECOMBINANT INTERLEUKIN 18; THIOPERAMIDE;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT REJECTION; HUMAN; HUMAN CELL; INFLAMMATION; MIXED LYMPHOCYTE REACTION; MONONUCLEAR CELL; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0037183861     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200209270-00021     Document Type: Article

References (45)

1. Romero M, Garcia MC, Clemente G, et al. Modulation of ICAM-1 expression in patients with liver transplantation (LT) and acute rejection (AR) after glucocorticoid treatment. Transpl Int 2000; 13: 456.
2. Fabrega E, Castro B, Crespo J, et al. Different time course of circulating adhesion molecules and hyaluran during hepatic allograft rejection. Transplantation 2000; 69: 569.
3. Park SY, Kim HW, Moon KC, et al. mRNA expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in acute renal allograft rejection. Transplantation 2000; 27: 2554.
4. von Willebbrand E, Sandberg M, Salmela K, et al. Expression of ICAM-1 and HLA class II in acute cellular and vascular rejection of human kidney allografts. Transpl Int 1994; 7: 308.
5. Katz SM, Bennett F, Stecker K, et al. ICAM-1 antisense oligodeoxynucleotide improves islet allograft survival and function. Cell Transplant 2000; 9: 817.
6. Rizzo M, SivaSai KS, Smith MA, et al. Increased expression of inflammatory cytokines and adhesion molecules by alveolar macrophages of human lung allograft recipients with acute rejection: Decline with resolution of rejection. Heart Lung Transplant 2000; 19: 858.
7. Zhang XP, Kelemen SE, Eisen HJ. Quantitative assessment of cell adhesion molecule gene expression in endomyocardial biopsy specimens from cardiac transplant recipients using competitive polymerase chain reaction. Transplantation 2000; 70: 505.
8. Zhu SN, Yamada J, Streilein JW, et al. ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants. Transplantation 2000; 69: 1008.
9. Takatsuka H, Takemoto Y, Okamoto T, et al. Adult respiratory distress syndrome-like disorders after allogeneic bone marrow transplantation. Transplantation 1999; 68: 1343.
10. Harrison PC, Mainolfi E, Madwed JB. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation. J Heart Lung transplant 1998; 17: 150.
11. Bumgardner GL, Li J, Heininger M, et al. Efficacy of anti-intercellular adhesion molecule-1 immunotherapy on immune responses to allogeneic hepatocytes in mice. Hepatology 1998; 28: 1005.
12. Genden EM, Mackinnon SE, Yu S, et al. Induction of donor-specific tolerance to rat nerve allografts with portal venous donor alloantigen and anti-ICAM-1/LFA-1 monoclonal antibodies. Surgery 1998; 124: 448.
13. Gorczynski RM, Chen Z, Zeng H, et al. A role for persisting antigen, antigen presentation and ICAM-1 in increased renal graft survival after oral or portal vein donor-specific immunization. Transplantation 1998; 66: 339.
14. Poston RS, Mann MJ, Hoyt EG, et al. Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method. Transplantation 1999; 68: 825.
15. Stepkowski SM. Development of antisense oligodeoxynucleotides for transplantation. Curr Opin Mol Ther 2000; 2: 304.
16. Affleck DG, Bull DA, Albanil A, et al. Interleukin-18 production following murine cardiac transplantation: Correlation with histologic rejection and the induction of IFN-gamma. J Interferon Cytokine Res 2001; 21: 1.
17. Yagi T, Iwagaki H, Urushihara N, et al. Participation of IL-18 in human cholestatic cirrhosis and acute rejection in living donor liver transplantation. Transplant Proc 2001; 33: 421.
18. Fujimori Y, Takatsuka H, Takemoto Y, et al. Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow. Br J Haematol 2000; 109: 652.
19. Nakamura H, Komatsu K, Ayaki M, et al. Serum levels of soluble IL-2 receptor, IL-12, IL-18 and IFN-gamma in patients with graft-versus-host disease after allogeneic bone marrow transplantation. J Allergy Clin Immunol 2000; 106: 45.
20. Chang DM, Wang CJ, Kuo SY, et al. Cell surface markers and circulating cytokines in graft versus host disease. Immunol Invest 1999; 28: 77.
21. Okamura H, Tsutsui H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378: 88.
22. Okamura H, Kashiwamura S, Yoshimoto T, et al. Regulation of interferongamma production by IL-12 and IL-18. Curr Opin Immunol 1998; 10: 259.
23. Yoshimoto T, Takeda K, Tanaka T, et al. IL-12 upregulates IL-18 receptor expression on T cells, Th1 cells and B cells: Synergism with IL-18 for IFN-gamma production. J Immunol 1998; 161: 3400.
24. Hu HZ, Li GL, Lim YK, et al. Kinetics of interferon-gamma secretion and its regulatory factors in the early phase of acute graft-versus-host disease. Immunology 1999; 98: 379.
25. Yoshida A, Kohka-Takahashi H, Nishibori M, et al. IL-18-induced expression of intercellular adhesion molecule-1 in human monocytes: Involvement in IL-12 and IFN-gamma production in PBMC. Cell Immunol 2001; 210: 160.
26. Elenkov IJ, Webster E, Papanicolaou DA, et al. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998; 161: 2586.
27. van der Pouw Kraan TC, Snijders A, Boeije LC, et al. Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J Clin Invest 1998; 102: 1866.
28. Takahashi KH, Yoshida A, Iwagaki H, et al. Histamine regulation of interleukin-18-initiating cytokine cascade is associated with down-regulation of intercellular adhesion molecule-1 expression in human peripheral blood mononuclear cells. J Pharmacol Exp Ther 2002; 300: 227.
29. Plaut M, Lichtenstein LM. Histamine ad immune responses. In: Ganellin CR, Parsons ME, eds. Pharmacology of histamine receptors. Bristol, Wright PSG, 1982, p 392.
30. Khan MM, Keaney KM, Melmon KL, et al. Histamine regulates the generation of human cytolytic T lymphocytes. Cell Immunol 1989; 121: 60.
31. Hellstrand K, Asea A, Dahlgren C, Hermodsson S. Histaminergic regulation of NK cells: Role of monocyte-derived reactive oxygen metabolites. J Immunol 1994; 153: 4940.
32. Dohlsten M, Sjogren HO, Carlsson R. Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-gamma production. Cell Immunol 1987; 109: 65.
33. Kohka H, Nishibori M, Iwagaki H, et al. Histamine is a potent inducer of IL-18 and IFN-γ in peripheral blood mononuclear cells. J Immunol 2000; 164: 6640.
34. Baib B, Vas MR, Lowenstein L. The development of large immature mononuclear cells in mixed leukocyte cultures. Blood 1964; 23: 271.
35. Bach F, Vagnaw NK. One way stimulation in mixed leukocyte cultures. Science 1966; 202: 271.
36. Black SJ, Duncan WAM, Durant GJ, et al. Definition and antagonism of histamine H2 receptors. Nature 1972; 236: 385.
37. Parsons ME, Owen DA, Ganellin CR, et al. Dimaprit-[S-[3-(N,N-dimethylamino)propyl]isothiourea: a highly specific histamine H2-receptor agonist. Part 1. Pharmacology. Agents Actions 1977; 7: 31.
38. Dustin ML, Springer TA. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989; 341: 619.
39. Stewart M, Hogg N. Regulation of leukocyte integrin function: Affinity vs. avidity. J Cell Biochem 1996; 61: 554.
40. Zhu SN, Yamada J, Streilein JW, et al. ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants. Transplantation 2000; 69: 1008.
41. Yoshida A, Kohka-Takahashi H, Iwagaki H, et al. Essential role of ICAM-1/LFA-1 interaction in synergistic effect of IL-18 and IL-12 on IFN-γ production in human PBMC. Naunyn Schmiedeberg's Arch Pharmacol 2002; 365: 181.
42. Kohka H, Iwagaki H, Yoshino T, et al. Involvement of interleukin-18 (IL-18) in mixed lymphocyte reactions (MLR). J Interferon Cytokine Res 1999; 19: 1053.
43. Ihm CG, Hong SP, Park JK, et al. Effects of mixed leukocyte reaction, hydrocortisone and cyclosporine on expression of leukocyte adhesion molecules by endothelial and mesangial cells. J Korean Med Sci 1996; 11: 495.
44. Koga S, Auerbach MB, Engeman TM, et al. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig. J Immunol 1999; 163: 4878.
45. Ring GH, Saleem S, Dai Z, et al. Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts. Transplantation 1999; 67: 1362.